SG Return on Equity (ROE) Analysis
Updated 902h ago·SEC filings & market data
Key Takeaway
Return on equity (ROE) measures how much profit a company generates for each dollar of shareholder equity; a 3.1% ROE means it earns about 3.1 cents per dollar of invested equity.
Sector Performance
21th percentileSG
3.1%
Sector Median
13.2%
Sector Avg
16.4%
Prior Period
3.6%(Jul 2026)
Deep Analysis
Return on equity (ROE) measures how much profit a company generates for each dollar of shareholder equity; a 3.1% ROE means it earns about 3.1 cents per dollar of invested equity.
This is far below the sector median of 13.4%, placing the stock in the 18th percentile among sector peers, so returns are weak relative to comparable companies. The year-over-year change and 8-quarter trend are not available, but the quarter-over-quarter change is -13.9%, with ROE falling from 3.6% to 3.1%. The combination of a low ROE and a recent decline suggests deteriorating profitability and elevated risk, offering limited opportunity for equity holders. This metric directly supports the overall CAUTIOUS verdict, as the company is underperforming its sector and showing negative momentum.
Frequently Asked Questions
What does the Return on Equity (ROE) tell investors about SG?
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
How is the Return on Equity (ROE) calculated?
Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.
Learn More About Return on Equity (ROE)
The Formula
Net Income / Shareholders' Equity
Why It Matters
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
Master SG's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full SG research report →SG
3.1%
Sector Median
13.2%
Sector Avg
16.4%
How SG's Return on Equity (ROE) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.